Avapritinib is indicated for the treatment of adults with metastatic gastrointestinal stromal tumors (GIST) harboring the PDGFRA D842V mutation; the drug is also used to treat systemic mastocytosis characterized by a KIT variant with the D816V mutation [30]. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.